Sorrento Therapeutics Banner Image

Sorrento Therapeutics

  • Ticker SRNE
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Sorrento Therapeutics Logo Image
  • 51-200 Employees
  • Based in San Diego, California
Sorrento Therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. Sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical CAR-T therapies targeting solid tumors.
Sorrento Therapeutics

Most Recent Annual Report

Sorrento Therapeutics MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Sorrento Therapeutics has reached its limit for free report views.

Sorrento Therapeutics does not currently have any hardcopy reports on AnnualReports.co.uk. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports